UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 575

Sortiert nach

Structural brain MRI studies in autism spectrum disorder

European psychiatry, 2023-03, Vol.66 (S1), p.S914-S914

2023

Volltextzugriff (PDF)

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Diabetologia, 2009-10, Vol.52 (10), p.2046-2055

2009

Volltextzugriff (PDF)

Cognitive behavioral therapy for patients with schizophrenia

European psychiatry, 2023-03, Vol.66 (S1), p.S1025-S1026

2023

Volltextzugriff (PDF)

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

Diabetic medicine, 2009-03, Vol.26 (3), p.268-278

2009

Volltextzugriff (PDF)

New horizons: further optimisation of the peri-operative cardiac arrest care preparedness

Anaesthesia, 2024-01, Vol.79 (1), p.11-14

2024

Volltextzugriff (PDF)

Consensus statement on fasting before procedural sedation – underestimating the threat to patient safety?

Anaesthesia, 2020-06, Vol.75 (6), p.829-830

2020

Volltextzugriff (PDF)

An international survey about rapid sequence intubation of 10,003 anaesthetists and 16 airway experts

Anaesthesia, 2020-03, Vol.75 (3), p.313-322

2020

Volltextzugriff (PDF)

The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: a retrospective multi-centre study

The Journal of hospital infection, 2023-07, Vol.137, p.1-7

2023

Volltextzugriff (PDF)

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

Diabetes, obesity & metabolism, 2009-12, Vol.11 (12), p.1163-1172

2009

Volltextzugriff (PDF)

Double trouble: myocardial infarction with non-obstructive coronary arteries as a presentation of Hughes syndrome in monozygotic twins

Lupus, 2020-04, Vol.29 (5), p.505-508

2020

Volltextzugriff (PDF)

The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome

Lupus, 2018-04, Vol.27 (5), p.858-863

2018

Volltextzugriff (PDF)

The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment

Diabetes, obesity & metabolism, 2013-10, Vol.15 (10), p.958-962

2013

Volltextzugriff (PDF)

The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men

Diabetologia, 2002-02, Vol.45 (2), p.195-202

2002

Volltextzugriff (PDF)

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

The Lancet (British edition), 2009-02, Vol.373 (9662), p.473-481

2009

Volltextzugriff (PDF)

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

Diabetic medicine, 2008-09, Vol.25 (9), p.1129-1131

2008

Volltextzugriff (PDF)

Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes

Diabetes research and clinical practice, 2008-08, Vol.81 (2), p.161-168

2008

Volltextzugriff (PDF)

Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

Diabetic medicine, 2008-02, Vol.25 (2), p.152-156

2008

Volltextzugriff (PDF)

Reduction in Pathogenic Biofilms by the Photoactive Composite of Bacterial Cellulose and Nanochitosan Dots under Blue and Green Light

Journal of functional biomaterials, 2024-03, Vol.15 (3), p.72

2024

Volltextzugriff (PDF)

P951: CLINICAL AND LABORATORY CHARACTERISTICS, COURSE AND OUTCOME OF COVID19 INFECTION IN PATIENTS WITH MULTIPLE MYELOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.841-842

2022

Volltextzugriff (PDF)

Bactericidal and antioxidant bacterial cellulose hydrogels doped with chitosan as potential urinary tract infection biomedical agent

RSC advances, 2021-02, Vol.11 (15), p.8559-8568

2021

Volltextzugriff (PDF)

Liver anatomy, intrahepatic vascular and biliary branching system of the mole rat (Spalax leucodon)

Folia morphologica, 2021-01, Vol.80 (4), p.888-894

2021

Volltextzugriff (PDF)

P658: COMPARISON OF CHARACTERISTICS AND OUTCOME OF COVID‐19 INFECTION IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASE AND IN PATIENTS FROM THE GENERAL POPULATION ‐ EXPERIENCE FROM THREE UNIVERSITY CENTERS

HemaSphere, 2022-06, Vol.6, p.556-557

2022

Volltextzugriff (PDF)

Pulse Wave Velocity: Retrospective Analysis in a Balkan Normotensive and Hypertensive Population: A Study of 9923 Patients

Angiology, 2018-01, Vol.69 (1), p.59-64

2018

Volltextzugriff (PDF)

Employing Gamma-Ray-Modified Carbon Quantum Dots to Combat a Wide Range of Bacteria

Antibiotics (Basel), 2023-05, Vol.12 (5), p.919

2023

Volltextzugriff (PDF)

The First Report of Stolbur Phytoplasma Associated with Phyllody of Calendula officinalis in Serbia

Plant disease, 2014-08, Vol.98 (8), p.1152-1152

2014

Volltextzugriff (PDF)

1 – 25 von 575

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(432)
Mit Volltextzugriff
(485)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(334)
Life Sciences & Biomedicine
(196)
Humans
(181)
Female
(117)
Technology
(115)
Male
(103)
Computer Science
(77)
Biological And Medical Sciences
(66)
Physical Sciences
(63)
Computer Science, Interdisciplinary Applications
(61)
Adult
(58)
Engineering
(57)
Middle Aged
(57)
Medical Sciences
(47)
Computer Science, Information Systems
(44)
Adolescent
(40)
Computer Science, Theory & Methods
(39)
Computer Science, Software Engineering
(37)
Engineering, Geological
(35)
Aged
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Structural brain MRI studies in autism spectrum disorder

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Cognitive behavioral therapy for patients with schizophrenia

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

New horizons: further optimisation of the peri-operative cardiac arrest care preparedness

Consensus statement on fasting before procedural sedation – underestimating the threat to patient safety?

An international survey about rapid sequence intubation of 10,003 anaesthetists and 16 airway experts

The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: a retrospective multi-centre study

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

Double trouble: myocardial infarction with non-obstructive coronary arteries as a presentation of Hughes syndrome in monozygotic twins

The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome

The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment

The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes

Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

Reduction in Pathogenic Biofilms by the Photoactive Composite of Bacterial Cellulose and Nanochitosan Dots under Blue and Green Light

P951: CLINICAL AND LABORATORY CHARACTERISTICS, COURSE AND OUTCOME OF COVID19 INFECTION IN PATIENTS WITH MULTIPLE MYELOMA

Bactericidal and antioxidant bacterial cellulose hydrogels doped with chitosan as potential urinary tract infection biomedical agent

Liver anatomy, intrahepatic vascular and biliary branching system of the mole rat (Spalax leucodon)

P658: COMPARISON OF CHARACTERISTICS AND OUTCOME OF COVID‐19 INFECTION IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASE AND IN PATIENTS FROM THE GENERAL POPULATION ‐ EXPERIENCE FROM THREE UNIVERSITY CENTERS

Pulse Wave Velocity: Retrospective Analysis in a Balkan Normotensive and Hypertensive Population: A Study of 9923 Patients

Employing Gamma-Ray-Modified Carbon Quantum Dots to Combat a Wide Range of Bacteria

The First Report of Stolbur Phytoplasma Associated with Phyllody of Calendula officinalis in Serbia

Suchergebnisse filtern